AAHKS LEARN

Welcome to the AAHKS LEARN Platform, the arthroplasty surgeon's go-to resource for online CME. View upcoming CME webinars and recordings by clicking "Courses" in the top left, or scroll down to the Courses section and click "view all". 

DISCLAIMER
The material presented at each live CME webinar is made available by AAHKS for educational purposes only. This content is not intended to represent the only method or practice appropriate for the medical situations discussed; it is intended to present a balanced and scientifically sound view, approach, statement or opinion of the faculty, which may be helpful to others who face similar situations, or afford a forum to discuss, debate and explore new and evolving topics. The presentation of topics and any data about clinical practices should not be interpreted as advocating for, or promoting, practices that are not, or not yet adequately based on current science, evidence and clinical reasoning.

FDA STATEMENT
Some pharmaceuticals and/or medical devices demonstrated or discussed have not been cleared by the US Food and Drug Administration (FDA) or have been cleared by the FDA for specific purposes only. The FDA has stated that it is the responsibility of the physician to determine the FDA clearance status of each pharmaceuticals and/or medical device he or she wishes to use in clinical practice. The AAHKS policy provides that “off label” status of the device or pharmaceutical is also specifically disclosed (i.e. that the FDA has not approved labeling the device for the described purpose). Any device or pharmaceutical is being used “off label” if the described use is not set forth on the product’s approved label.

DISCLOSURE
Many health care professionals have financial relationships with ineligible companies. These relationships must not be allowed to influence accredited continuing education. AAHKS is responsible for identifying relevant financial relationships between individuals in control of educational content and ineligible companies and managing these to ensure they do not introduce commercial bias into the education. Financial relationships of any dollar amount are defined as relevant if the educational content is related to the business lines or products of the ineligible company.

Definition of ineligible company: Those companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. Examples of such organizations include:

• Advertising, marketing, or communication firms whose clients are ineligible companies.
• Bio-medical startups that have begun a governmental regulatory approval process.
• Compounding pharmacies that manufacture proprietary compounds.
• Device manufacturers or distributors.
• Diagnostic labs that sell proprietary products.
• Growers, distributors, manufacturers or sellers of medical foods and dietary supplements.
• Manufacturers of health-related wearable products Pharmaceutical companies or distributors.
• Pharmaceutical companies or distributors.
• Pharmacy benefit managers Reagent manufacturers or sellers